Park Square Places Greg Hoffman, Ph.D. as Vice President, Platform Biology at Deep Genomics
Park Square has placed Greg Hoffman, Ph.D. as Vice President, Platform Biology at Deep Genomics. Deep Genomics is a pioneering...
Park Square has placed Greg Hoffman, Ph.D. as Vice President, Platform Biology at Deep Genomics. Deep Genomics is a pioneering...
Park Square is pleased to announce the placement of Anna Goranson as Chief People Officer at Terray Therapeutics. Terray is a pioneering...
Park Square is pleased to announce the placement of Charles Allerson, Ph.D., as Chief Technology Officer at Switch Therapeutics.
Switch Therapeutics, a biotechnology company pioneering a new way to use RNA science to treat diseases utilizing its proprietary CASi...…
Park Square has placed Debbie Chirnomas as Chief Medical Officer at Faeth Therapeutics.
“Dr. Chirnomas will help the company advance our pipeline of metabolically-driven therapeutics targeting multiple cancers. Debbie comes...…
Park Square places Steven Basta as Chief Executive Officer at SaNOtize.
SaNOtize Research and Development Corp. (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced that the...…
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net